YSP Southeast Asia Holding Bhd
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, an… Read more
YSP Southeast Asia Holding Bhd (7178) - Net Assets
Latest net assets as of September 2025: RM416.46 Million MYR
Based on the latest financial reports, YSP Southeast Asia Holding Bhd (7178) has net assets worth RM416.46 Million MYR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM536.26 Million) and total liabilities (RM119.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM416.46 Million |
| % of Total Assets | 77.66% |
| Annual Growth Rate | 5.18% |
| 5-Year Change | 19.39% |
| 10-Year Change | 54.93% |
| Growth Volatility | 2.5 |
YSP Southeast Asia Holding Bhd - Net Assets Trend (2012–2024)
This chart illustrates how YSP Southeast Asia Holding Bhd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for YSP Southeast Asia Holding Bhd (2012–2024)
The table below shows the annual net assets of YSP Southeast Asia Holding Bhd from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | RM409.02 Million | +3.53% |
| 2023-12-31 | RM395.06 Million | +6.15% |
| 2022-12-31 | RM372.16 Million | +7.40% |
| 2021-12-31 | RM346.50 Million | +1.14% |
| 2020-12-31 | RM342.60 Million | +4.39% |
| 2019-12-31 | RM328.19 Million | +4.17% |
| 2018-12-31 | RM315.05 Million | +8.82% |
| 2017-12-31 | RM289.51 Million | +5.51% |
| 2016-12-31 | RM274.41 Million | +3.94% |
| 2015-12-31 | RM264.00 Million | +10.46% |
| 2014-12-31 | RM239.00 Million | +3.91% |
| 2013-12-31 | RM230.00 Million | +3.14% |
| 2012-12-31 | RM223.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to YSP Southeast Asia Holding Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 84.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM254.62 Million | 62.25% |
| Common Stock | RM154.40 Million | 37.75% |
| Total Equity | RM409.02 Million | 100.00% |
YSP Southeast Asia Holding Bhd Competitors by Market Cap
The table below lists competitors of YSP Southeast Asia Holding Bhd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Soluna Holdings Inc
NASDAQ:SLNH
|
$21.45 Million |
|
Stream Media Corporation
PINK:STEAF
|
$21.46 Million |
|
Rapala VMC Oyj
HE:RAP1V
|
$21.46 Million |
|
Buda Juice, Inc.
NYSE MKT:BUDA
|
$21.46 Million |
|
Western Alaska Minerals Corp
PINK:WAMFF
|
$21.44 Million |
|
MIMDF
OTCQB:MIMDF
|
$21.43 Million |
|
KPX Lifescience.Co.Ltd
KQ:114450
|
$21.42 Million |
|
ENEFIT GREEN AS
F:I6B
|
$21.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in YSP Southeast Asia Holding Bhd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 395,058,000 to 409,021,000, a change of 13,963,000 (3.5%).
- Net income of 26,688,000 contributed positively to equity growth.
- Dividend payments of 15,603,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM26.69 Million | +6.52% |
| Dividends Paid | RM15.60 Million | -3.81% |
| Other Changes | RM2.88 Million | +0.7% |
| Total Change | RM- | 3.53% |
Book Value vs Market Value Analysis
This analysis compares YSP Southeast Asia Holding Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.71x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.01x to 0.71x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | RM2.04 | RM2.06 | x |
| 2017-12-31 | RM2.12 | RM2.06 | x |
| 2018-12-31 | RM2.28 | RM2.06 | x |
| 2019-12-31 | RM2.37 | RM2.06 | x |
| 2020-12-31 | RM2.26 | RM2.06 | x |
| 2021-12-31 | RM2.46 | RM2.06 | x |
| 2022-12-31 | RM2.64 | RM2.06 | x |
| 2023-12-31 | RM2.79 | RM2.06 | x |
| 2024-12-31 | RM2.88 | RM2.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently YSP Southeast Asia Holding Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.52%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.24%
- • Asset Turnover: 0.70x
- • Equity Multiplier: 1.29x
- Recent ROE (6.52%) is below the historical average (7.75%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 10.06% | 11.64% | 0.70x | 1.24x | RM153.30K |
| 2017 | 7.04% | 7.79% | 0.71x | 1.28x | RM-8.57 Million |
| 2018 | 9.63% | 10.51% | 0.70x | 1.31x | RM-1.16 Million |
| 2019 | 7.01% | 7.78% | 0.68x | 1.32x | RM-9.81 Million |
| 2020 | 6.41% | 7.40% | 0.66x | 1.31x | RM-12.28 Million |
| 2021 | 4.38% | 5.39% | 0.63x | 1.29x | RM-19.47 Million |
| 2022 | 9.26% | 10.31% | 0.71x | 1.27x | RM-2.75 Million |
| 2023 | 9.45% | 10.51% | 0.68x | 1.32x | RM-2.19 Million |
| 2024 | 6.52% | 7.24% | 0.70x | 1.29x | RM-14.21 Million |
Industry Comparison
This section compares YSP Southeast Asia Holding Bhd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $107,405,045
- Average return on equity (ROE) among peers: 12.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| YSP Southeast Asia Holding Bhd (7178) | RM416.46 Million | 10.06% | 0.29x | $21.44 Million |
| Kotra Industries Bhd (0002) | $65.03 Million | 15.36% | 0.20x | $23.04 Million |
| PeterLabs Holdings Bhd (0171) | $45.74 Million | 8.76% | 0.51x | $3.70 Million |
| Rhone Ma Holdings Bhd (5278) | $160.98 Million | 7.50% | 0.43x | $4.26 Million |
| Duopharma Biotech Bhd (7148) | $157.87 Million | 18.16% | 0.24x | $132.90 Million |